TrianglePUBLICATIONS · 15447992
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2004 Sep 15
- First author
- Spunt SL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Spunt SL
- type
- Author
- name
- Smith LM
- type
- Author
- name
- Ruymann FB
- type
- Author
- name
- Qualman SJ
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Rodeberg DA
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Crist WM
- type
- Author
- name
- Link MP
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Spunt SL
- type
- Author
- name
- Smith LM
- type
- Author
- name
- Ruymann FB
- type
- Author
- name
- Qualman SJ
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Rodeberg DA
- type
- Author
- name
- Anderson JR
- type
- Author
- name
- Crist WM
- type
- Author
- name
- Link MP
- type
- Author
- bibliography ids
- nci-bib-6ec4a2430b0920041ba57392
- book metadata
- content sha256
- be581a77fd4d1612180c74237f465df4b908e911edba4a2d8ec1c5012c298999
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-04-0654
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15447992
- immutable id
- pubmed:15447992@be581a77fd4d1612180c74237f465df4b908e911edba4a2d8ec1c5012c298999
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- Source null
- issn print
- 1078-0432
- issue
- 18 Pt 1
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 6072-9
- volume
- 10
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15447992
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- 10342e2b40ba76cdb3e81860398b889595de2afffc64e23134232bc7ebfcd87c
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2004 Sep 15
- precision
- day
- year
- 2004
- publication types
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Preserved source evidence · Not medical advice